Table 5. Quality assessment of RCTs.
| Study | Random sequence generation | Allocation concealment | Blinding of participants and personnel | Blinding of outcome assessment | Incomplete outcome data | Selective reporting | Other bias |
|---|---|---|---|---|---|---|---|
| SELECT-D | Low | Low | High | Low | Low | Low | Low |
| Hokusai VTE Cancer | Low | Unclear | High | Low | Low | Low | Low |
| AMPLIFY | Low | Low | Low | Low | Low | Low | Low |
| EINSTEIN-PE/DVT | Low | Unclear | High | Low | Low | Low | Low |
| Hokusai-VTE | Low | Unclear | Low | Low | Low | Low | Low |
| RECOVER-I/II | Low | Low | Low | Low | Low | Low | Low |
RCT, randomized controlled trial; Low, low risk; unclear, unclear risk; High, high risk.